Government Affairs
Refine Search
Pharmaceutical
The president of Greek industry association the Hellenic Association of Pharmaceutical Companies (SFEE), painted an alarming picture on the current and future state of Greek healthcare at the group’s general assembly meeting. 8 April 2019
Pharmaceutical
A major fillip has been provided by the Indian government for new drugs approved for use in the EU, UK, Australia, Japan and the USA. Newly-minted clinical trial rules in India state drugs that have been approved in these countries no longer require trials in India, reports The Pharma Letter’s India correspondent. 5 April 2019
Pharmaceutical
The year-long US-China tension demands a fairer Chinese market access for global companies, and it might benefit China’s drug innovation, said speakers at the annual China Healthcare Investment Conference (CHIC) event held in Shanghai on March 27. 4 April 2019
Biotechnology
Major US insurer Cigna has moved to cap insulin prices for customers, together with its new acquisition Express Scripts, a pharmacy benefits manager (PBM). 4 April 2019
Pharmaceutical
Next week will be the turn of insulin manufacturers to testify about US drug prices in the House of Representatives. 3 April 2019
Pharmaceutical
Medicines Australia welcomes the announcement of A$331 million ($236 million) for the listings of innovative medicines on the country’s Prescription Benefits Scheme (PBS) in today’s 2019/20 Federal Budget. 2 April 2019
Pharmaceutical
The Hungarian pharmaceutical industry has urged government to make it easier to access subsidies to promote drug development. 1 April 2019
Pharmaceutical
The Maryland House of Delegates this week voted 98 to 40 to create a Prescription Drug Affordability Board, an independent body with the authority to evaluate high-cost prescription drugs and set rates for state and local governments to pay. 29 March 2019
Pharmaceutical
Péter Holchacker, director of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), has said that the country’s medicines budget is 20 billion Hungarian forint ($71 million) behind what it was a decade ago. 25 March 2019
Pharmaceutical
The Australian government is providing almost A$25 million ($17.8 million) so Australians with cancer and rare diseases have access to clinical trials no matter where they live including regional and remote Victoria. 25 March 2019
Pharmaceutical
Stepping up its warnings of what could happen if the process of setting US drug prices were to be radically reformed, PhRMA has quoted analysis by intelligence provider Xcenda. 22 March 2019
Pharmaceutical
The World Health Organization (WHO) has issued new guidance with the aim of improving the treatment of multidrug resistant tuberculosis (MDR-TB). 21 March 2019
Generics
A piquant situation has emerged in India. The Indian government's generic medicine scheme is hurting the local pharmaceutical market, and is proving to be a major challenge for branded generic players. 20 March 2019
Pharmaceutical
US trade association PhRMA is concerned about proposed changes to the Medicare Part D program. 18 March 2019
Pharmaceutical
The Office of the US Trade Representative (USTR)’s 2019 Special 301 Report – scheduled to be released this spring – brings critical attention to overseas intellectual property (IP) and market access challenges that harm American innovators, patients and workers. 15 March 2019
Pharmaceutical
In a change of policy, Italian children have been told not to turn up to school unless they can prove they have been properly vaccinated. The decision follows months of national debate over compulsory vaccination. 14 March 2019
Pharmaceutical
Reflecting its growing standing as an opinion leader on all things drug price-related, the Institute for Clinical and Economic Review (ICER)—in collaboration with the Office of Health Economics (OHE) —has published a white paper looking at alternative models for pharmaceutical rebates in the USA. 13 March 2019
Pharmaceutical
Even if the UK parliament votes against ‘no deal’ on Wednesday, in the wacky world of Brexit, this cliff-edge scenario is still possible – so Stevens & Bolton partner Charlotte Tillett and senior associate Paula Harris, consider the potential implications for pharma in an Expert View piece. 13 March 2019
Pharmaceutical
Following the unexpected resignation of incumbent Dr Scott Gottlieb earlier this month, the Trump administration on Tuesday announced that National Cancer Institute (NCI) Director Norman (Ned) Sharpless will serve as acting Commissioner of the US Food and Drug Administration. 13 March 2019
Pharmaceutical
US President Donald Trump has made slashing drug prices a priority in his fiscal year 2020 budget. 12 March 2019
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze